CLINICAL_TRIALS
trial_result
· 2024-10-21
Clinical Trial Update: Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA [Phase 1, Phase 2]
Summary
Results from a Phase 1/2 study evaluating intravaginal tamoxifen for vulvar atrophy in postmenopausal women have been completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daré Bioscience, Inc. | Conditions: Vulvar Atrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-21